Hangzhou-based regenerative medicine company developing cell reprogramming and functional tissue transplantation therapies
Hangzhou-based regenerative medicine company developing cell reprogramming and functional tissue transplantation therapies.
The top three firms on F4's Biotech & Life Sciences investor list.